Spire Healthcare Group (LON:SPI) Trading 14.1% Higher - Should You Buy?

Key Points

• Spire Healthcare Group's stock price surged 14.1% to a high of GBX 256.50 ($3.46), with trading volume increasing by 563% compared to the average session volume.
• Equities research analysts have expressed optimism with a consensus rating of "Buy" and an average target price of GBX 294.33 for Spire Healthcare Group shares.
• The company reported a quarterly earnings per share (EPS) of GBX 4.10, with expectations to post an EPS of 15.66 for the current fiscal year.

Spire Healthcare Group plc (LON:SPI - Get Free Report)'s stock price shot up 14.1% during mid-day trading on Saturday . The company traded as high as GBX 256.50 ($3.47) and last traded at GBX 247 ($3.34). 9,747,062 shares changed hands during mid-day trading, an increase of 563% from the average session volume of 1,469,073 shares. The stock had previously closed at GBX 216.50 ($2.93).

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on SPI shares. JPMorgan Chase & Co. decreased their price objective on Spire Healthcare Group from GBX 309 to GBX 303 and set an "overweight" rating on the stock in a report on Tuesday, August 5th. Berenberg Bank restated a "buy" rating and set a GBX 280 price target on shares of Spire Healthcare Group in a report on Thursday, July 31st. Three investment analysts have rated the stock with a Buy rating, According to MarketBeat.com, the company presently has a consensus rating of "Buy" and an average target price of GBX 294.33.

Spire Healthcare Group Stock Performance

The business has a 50-day moving average of GBX 218.99 and a two-hundred day moving average of GBX 203.96. The company has a debt-to-equity ratio of 62.25, a current ratio of 0.70 and a quick ratio of 0.74. The company has a market cap of £983.80 million, a P/E ratio of 5,315.22, a P/E/G ratio of 1.06 and a beta of 0.96.

Spire Healthcare Group (LON:SPI - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The company reported GBX 4.10 EPS for the quarter. Spire Healthcare Group had a return on equity of 3.82% and a net margin of 1.96%. On average, sell-side analysts predict that Spire Healthcare Group plc will post 15.6634747 EPS for the current fiscal year.

About Spire Healthcare Group

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.